A
Adrian C Bateman
Researcher at University Hospital Southampton NHS Foundation Trust
Publications - 146
Citations - 8121
Adrian C Bateman is an academic researcher from University Hospital Southampton NHS Foundation Trust. The author has contributed to research in topics: Cancer & Neoadjuvant therapy. The author has an hindex of 42, co-authored 142 publications receiving 7188 citations. Previous affiliations of Adrian C Bateman include Royal Hampshire County Hospital & National Health Service.
Papers
More filters
Journal ArticleDOI
Comparing virtual with conventional microscopy for the consensus diagnosis of Barrett’s neoplasia in the AspECT Barrett’s chemoprevention trial pathology audit
D S A Sanders,Heike Grabsch,Rebecca Harrison,Adrian C Bateman,James J. Going,Robert D. Goldin,Nicholas Mapstone,Marco Novelli,Marjorie M. Walker,Janusz Jankowski +9 more
TL;DR: Histopathology 61, 795–800 shows clear trends in prognosis for central giant cell granuloma in women over a period of decades, with clear patterns of prognosis and disease progression.
Journal ArticleDOI
Chronic gastric ulceration: a novel manifestation of IgG4-related disease?
TL;DR: A 73-year-old woman who presented with anaemia and gastroscopy revealed a 30 mm firm ulcer with raised edges at the lesser curve of the stomach, which proceeded to laparotomy with partial gastrectomy, after which she made an uneventful recovery.
Journal ArticleDOI
Systemic neoadjuvant chemotherapy in modern pancreatic cancer treatment: a systematic review and meta-analysis
TL;DR: Current evidence suggests that neoadjuvant chemotherapy has a beneficial effect on overall survival in resectable pancreatic ductal adenocarcinoma in comparison with upfront surgery and adjuvant therapy.
Journal ArticleDOI
Lymph node revealing solutions in colorectal cancer: should they be used routinely?
TL;DR: In this article, the authors reviewed the evidence that lymph node revealing solutions significantly improve lymph node harvesting, and that glacial acetic acid, ethanol, water and formalin is advantageous in comparison with other revealing solutions in that it is safe, cheap, easy to use and relatively quick.
Journal ArticleDOI
Developing a ‘traffic light’ test with potential for rational early diagnosis of liver fibrosis and cirrhosis in the community
TL;DR: A simple blood test triages liver disease into three prognostic groups; used in the community, it could enhance the management of risk factors in primary care and rationalise secondary care referrals, including the many patients with fatty liver and relatively minor elevations in alanine transaminase.